Bellafill Brow Lift: Nonsurgical, Immediate, and Long-Lasting

Introduction: Management of the aging brow has classically involved surgical therapy. Energy-based devices causing skin tightening, neuromodulators, or brow dermal filler volume placement can create brow lifting. Materials & Methods: Retrospective, consecutive patient review of Artefill (ART), now Bellafill, injection along superior brow hair to provide permanent brow lifting. The degree of brow suspension was evaluated regarding the medial, peek, and lateral brow calibrated measurements, injection site filler placement, complications, and patient satisfaction. Results: From 2015 through 2022, 113 patients underwent ART (Bellafill) brow lifting alone or simultaneously with upper cosmetic eyelid surgery (blepharoplasty). Using the global aesthetic improvement scale (GAIS) assessment reached 88.5% patient satisfaction with very much improved or improved responses. Brow measurements showed 80.0% having brow elevation by mean of 2.13 mm with 92% required one syringe (half of syringe per side) and injecting with a 25 G microcannula in 96%. The only side effect or complication observed was bruising (5.3%). Conclusions: Bellafill (ART) brow lift is a safe and effective minimally invasive procedure that uses no anesthesia (except synthetic ice) with microcannula filler administration, which reduces side effects and complications. This technically simple procedure provides long-term brow lift results comparable with surgical therapy outcomes in selected patients.